Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-κβ in hyperhomocysteinemia

Journal of Cellular Physiology

Volumn 215, Issue 3, 2008, Pages 771-781

  Moshal, Karni S ^a   Zeldin, Darryl C ^b   Sithu, Srinivas D ^a   Sen, Utpal ^a   Tyagi, Neetu ^a   Kumar, Munish ^a   Hughes Jr , William M ^a   Metreveli, Naira ^a   Rosenberger, Dorothea S E ^a   Singh, Mahavir ^a,c   Vacek, Thomas P ^a   Rodriguez, Walter E ^a   Ayotunde, Adeagbo ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c Potentia Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2J2; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; 8,9 EPOXYICOSATRIENOIC ACID; 8,9-EPOXYEICOSATRIENOIC ACID; ARACHIDONATE EPOXYGENASE; CYTOCHROME P450; DIHOMO GAMMA LINOLENIC ACID; DRUG DERIVATIVE; HOMOCYSTEINE; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; OXYGENASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HYPERHOMOCYSTEINEMIA; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; GENETICS; METABOLISM; PHOSPHORYLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 8,11,14-EICOSATRIENOIC ACID; ANIMALS; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME ACTIVATION; ENZYME INDUCTION; HOMOCYSTEINE; HYPERHOMOCYSTEINEMIA; I-KAPPA B PROTEINS; MATRIX METALLOPROTEINASE 9; MICE; OXYGENASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; TRANSCRIPTION FACTOR RELA; TRANSFECTION;

EID: 42949129592     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21356     Document Type: Article

References (35)

1. Creemers EEJM, Cleuthens JPM, Smits JFM, Daemen MJAP. 2001. Matrix metalloproteinase after myocardial infarction a new approach to prevent heart failure. Circ Res 89:201-210.
2. Fitzpatrick FA, Ennis MD, Baze ME, Wynalda MA, McGee JE, Liggett WF. 1986. Inhibition of cyclo-oxygenase activity and platelet aggregation by epoxyeicosatrienoic acids. Influence of stereochemistry. J Biol Chem 261:15334-15338.
3. Fleming I, Fisslthaler B, Michaelis UR, Kiss L, Popp R, Busse R. 2001. The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation in vascular cells. Pflugers Arch 442:511-518.
4. Galis ZS, Khatri JJ. 2002. Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ Res 90:251-262.
5. Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, Ferran LJ, Jr., Kohl B, Rao V, Kisiel W, Stern DM, Schmidt AM. 2001. Hyperhomocysteinaemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 107:675-683.
6. Ko HM, Kang JH, Choi JH, Park SJ, Bai S, Im SY. 2005. Platelet-activating factor induces matrix metalloproteinase-9 expression through Ca 2+- or PI3K-dependent signaling pathway in a human vascular endothelial cell line. FEBS Lett 579:6451-6458.
7. Lee SD, Wu CC, Chang YC, Chang SH, Wu CH, Wu JP, Hwang JM, Kuo WW, Liu JY, Huang CY. 2006. Porphyromonas gingivalis-induced cellular hypertrophy and MMP-9 activity via different signaling pathways in H9c2 cardiomyoblast cells. J Periodontol 77:684-691.
8. Leoncini G, Bruzzese D, Signorello MG. 2006. Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets. J Thromb Haemost 4:209-216.
9. Ma J, Qu W, Scarborough PE, Tomer KB, Moomaw CR, Maronpot R, Davis LS, Breyer MD, Zeldin DC. 1999. Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome P450 highly expressed in kidney. J Biol Chem 274:17777-17788.
10. Michaelis UR, Fleming I. 2006. From endothelium-derived hyperpolarizing factor (EDHF) to angiogenesis: Epoxyeicosatrienoic acids (EETs) and cell signaling. Pharmacol Ther 111:584-595.
11. Michaelis UR, Fisslthaler B, Barbosa-Sicard E, Falck JR, Fleming I, Busse R. 2005. Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis. J Cell Sci 118:5489-5498.
12. Miller A, Mujumdar V, Shek E, Guillot J, Angelo M, Palmer L, Tyagi SC. 2000. Hyperhomocyst(e)inemia induces multiorgan damage. Heart Vessels 15:135-143.
13. Miller A, Mujumdar V, Palmer L, Bower JD, Tyagi SC. 2002. Reversal of endocardial endothelial dysfunction byfolic acid in homocysteinemic hypertensive rats. Am J Hypertens 15:157-163.
14. Moshal KS, Tyagi N, Henderson B, Ovechkin AV, Tyagi SC. 2005. Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure. Am J Physiol Heart Circ Physiol 288:H2770-H2777.
15. Moshal KS, Sen U, Tyagi N, Henderson B, Steed M, Ovechkin AV, Tyagi SC. 2006. Regulation of homocysteine-induced MMP-9 by ERK1/2 pathway. Am J Physiol Cell Physiol 290:C883-C891.
16. Moshal KS, Singh M, Sen U, Rosenberger DS, Henderson BC, Tyagi N, Zhang H, Tyagi SC. 2006. Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC. Am J Physiol Heart Circ Physiol 291:H2825-H2835.
17. Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, Liao JK. 1999. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285:1276-1279.
18. Philip S, Kundu GC. 2003. Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J Biol Chem 278:14487-14497.
19. Signorello MG, Pascale R, Leoncini G. 2002. Effect of homocysteine on arachidonic acid release in human platelets. Eur J Clin Invest 32:279-284.
20. Snyder GD, Krishna UM, Falck JR, Spector AA. 2002. Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle. Am J Physiol 283:H1936-H1942.
21. Solini A, Santini E, Nannipieri M, Ferrannini E. 2006. High glucose and homocysteine synergistically affect the metalloproteinases-tissue inhibitors of metalloproteinases pattern, but not TGFB expression, in human fibroblasts. Diabetologia 49:2499-2506.
22. Spinale FG. 2002. Matrix metalloproteinases regulation and dysregulation in the failing heart. Circ Res 90:520-530.
23. Suhara T, Fukuo K, Yasuda O, Tsubakimoto M, Takemura Y, Kawamoto H, Yokoi T, Mogi M, Kaimoto T, Ogihara T. 2004. Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways. Hypertension 43:1208-1213.
24. Sun J, Sui X, Bradbury JA, Zeldin DC, Conte MS, Liao JK. 2002. Inhibition of vascular smooth muscle cell migration by cytochrome P450 epoxygenase-derived eicosanoids. Circ Res 90:1020-1027.
25. Tyagi N, Sedoris KC, Steed M, Ovechkin AV, Moshal KS, Tyagi SC. 2005. Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol 289:H2649-H2656.
26. Ungvari Z, Csiszar A, Bagi Z, Koller A. 2002. Impaired nitric oxide-mediated flow induced coronary dilation in hyperhomocysteinemia: Morphological and functional evidence for increased peroxynitrite formation. Am J Pathol 161:145-153.
27. Vane JR, Botting RM. 1995. Pharmacodynamic profile of prostacyclin. Am J Cardiol 75:3A-10A.
28. Wang G, Siow YL, O K. 2000. Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: A possible role for protein kinase C. Biochem J 352:817-826.
29. Wang Y, Wei X, Xiao X, Hui R, Card JW, Carey MA, Wang DW, Zeldin DC. 2005. Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways. J Pharmacol Exp Ther 314:522-532.
30. Wang L, Zhang ZG, Zhang RL, Gregg SR, Hozeska-Solgot A, LeTourneau Y, Wang Y, Chopp M. 2006. Matrix metalloproteinase 2 (MMP-2) and MMP-9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. J Neurosci 26:5996-6003.
31. Wong PY, Lai PS, Falck JR. 2000. Mechanism and signal transduction of 14 (R), 15 (S)-epoxyeicosatrienoic acid (14,15-EET) binding in guinea pig monocytes. Prostaglandins Other Lipid Mediat 62:321-333.
32. Wu S, Chen W, Murphy E, Gabel S, Tomer KB, Foley J, Steenbergen C, Falck JR, Moomaw CR, Zeldin DC. 1996. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart myocytes. J Biol Chem 271:3460-3468.
33. Yang B, Graham L, Dikalov S, Mason RP, Falck JR, Liao JK, Zeldin DC. 2001. Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells. Mol Pharmacol 60:310-320.
34. Zhang HS, Cao EH, Qin JF. 2005. Homocysteine induces cell cycle G1 arrest in endothelial cells through the PI3K/Akt/FOXO signaling pathway. Pharmacology 74:57-64.
35. Zhu JH, Chen JZ, Wang XX, Xie XD, Sun J, Zhang FR. 2006. Homocysteine accelerates senescence and reduces proliferation of endothelial progenitor cells. J Mol Cell Cardiol 40:648-652.